Receptor News and Research

RSS

Researchers discover mechanism that shuts down cell-to-cell communications pathway

Cellular functions rely on several communications networks that allow cells to rapidly respond to signals affecting the organism.

10 Jul 2018

Study: Mitochondrial DNA in nanovesicles is the alarm that activates antiviral genetic program

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III have provided valuable information about the defense mechanisms of the immune system during the early stages of the response to pathogens such as viruses and bacteria.

10 Jul 2018

Ludwig-developed antibody drug for deadly brain cancer may have broader applications

A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor, a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme.

10 Jul 2018

Scientists create predictive model for neuroblastoma that incorporates early developmental signals

Neuroblastoma, a rare childhood cancer of the sympathetic nervous system, is particularly deadly because it is difficult to detect and thus generally advanced before treatment begins.

9 Jul 2018

Study uncovers how a sticky protein promotes activity of estrogen in breast cancer cells

New research uncovers how a sticky protein called fibronectin promotes the activity of estrogen in breast cancer cells.

9 Jul 2018

Study finds common risk gene for both job-related exhaustion in shift workers and Alzheimer's

A Finnish study published in the respected SLEEP journal shows that a variation in the melatonin receptor 1A (MTNR1A) gene is linked to the risk of Alzheimer's disease in the elderly.

6 Jul 2018

Fourth-generation retinoid may have improved efficacy and safety profile to treat acne

Topical retinoids, which target retinoic acid receptors, are commonly used to treat acne. New research published in theBritish Journal of Dermatologyreveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety profile compared with less selective retinoids.

6 Jul 2018

Nanofiber-based wound dressings loaded with vitamin D spur production of antimicrobial peptide

Nanofiber-based wound dressings loaded with vitamin D spur the production of an antimicrobial peptide, a key step forward in the battle against surgical site infections, or SSIs.

6 Jul 2018

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Faced with the epidemic of opioid addiction, researchers have been charged with finding other strategies to treat pain. Their efforts largely have focused on nerve cells that transmit pain signals to the spinal cord and brain.

6 Jul 2018

Seeing the Unexpected: Regulatory T Cells and Basophils

Dr. Jagadeesh Bayry from INSERM discusses his recent research in the field of immunology, and how T regulatory cells activate, rather than suppress, basophils.

4 Jul 2018

Study: Mice that lack certain brain receptor get attracted to situations associated with discomfort

The brains of both humans and other animals have circuits that connect powerful impressions from the senses to positive or negative feelings - a function that is necessary for survival.

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Researchers find new marker for better prognosis in gastric and esophageal cancer

Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.

2 Jul 2018

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

Streamlining and translating basic science discoveries into the clinic

To make sure that good ideas to enhance healthcare are not lost due to a lack of resources, a growing number of centers at Penn Medicine organize forums to pitch ideas to improve medical devices and technology, hold annual competitions to fund studies to improve patient care while keeping costs down, and sponsor seed grants for programs focused on patients who need individualized tailoring of their treatment.

2 Jul 2018

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.

30 Jun 2018

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.

30 Jun 2018

Researchers discover novel function of fibroblast growth factor 2 for spermatogonial stem cell

A research team found a novel function of fibroblast growth factor 2, a self-renewal factor for spermatogonial stem cell which is the origin of the sperm production.

30 Jun 2018

New therapeutic may help drug addicts avoid future drug use

A new therapeutic may help reverse chemical imbalances made to the brain by habitual drug use and could one day help recovering drug addicts avoid future drug use.

30 Jun 2018

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator on the first trial and as local PI on three other trials.

30 Jun 2018

Receptor News and Research

Researchers discover mechanism that shuts down cell-to-cell communications pathway

Study: Mitochondrial DNA in nanovesicles is the alarm that activates antiviral genetic program

Ludwig-developed antibody drug for deadly brain cancer may have broader applications

Scientists create predictive model for neuroblastoma that incorporates early developmental signals

Study uncovers how a sticky protein promotes activity of estrogen in breast cancer cells

Study finds common risk gene for both job-related exhaustion in shift workers and Alzheimer's

Fourth-generation retinoid may have improved efficacy and safety profile to treat acne

Nanofiber-based wound dressings loaded with vitamin D spur production of antimicrobial peptide

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Seeing the Unexpected: Regulatory T Cells and Basophils

Study: Mice that lack certain brain receptor get attracted to situations associated with discomfort

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Researchers find new marker for better prognosis in gastric and esophageal cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Streamlining and translating basic science discoveries into the clinic

KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-positive breast cancer

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

Researchers discover novel function of fibroblast growth factor 2 for spermatogonial stem cell

New therapeutic may help drug addicts avoid future drug use

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News